Over the last couple of months, I’ve written periodically about cancer research and the complaints that the present system of funding grants and of peer review stifles innovation, as well as whether ideas for which there is some evidence but which fall out of the mainstream are given a fair shake. My overall take has […]
Category: Clinical trials
I’ve been meaning to go through the recent meta-analysis of Avandia published by the New England Journal of Medicine that purported to show major increase in the risk for cardiac events (myocardial infarctions and cardiac death) in patients who use Avandia, but somehow never got around to it. I’m not sure I need to now, […]
Share this:
Our creationist neurosurgeon, Dr. Michael Egnor, isn’t going to like this one bit. No doubt he’ll try to call it “artificial selection” or a “tautology” when he finds out about it, if he doesn’t just ignore it because he it doesn’t fit in with his view that studying evolution is “of no value” in medicine. […]
Share this:
I’ve complained on multiple occasions about the infiltration of non-evidence-based “medicine” (a.k.a. woo) into every level of medicine in the U.S.. Worst of all, it’s infiltrating medical education in a big way, starting with the pro-woo activism of the American Medical Student Association (AMSA), to various educational programs in various medical schools, to even the […]
Share this:
I hadn’t planned on revisiting this topic again quite so soon, but sometimes a piece of information comes up that’s so disturbing that I can’t ignore it and can’t justify delaying blogging about it by very long. So it is yet again with the strange and disturbing saga of dichloroacetate (DCA), the small molecular chemotherapeutic […]
